Stem cell therapy is the purest cash market in American medicine. There is no insurance code, no negotiated rate and no Medicare fee schedule to anchor against, so every clinic sets its own number and the spread between them is enormous. Two practices a few miles apart can quote very different amounts for what sounds to a patient like the same injection.
This guide prices the market as it actually works in September 2026, using clinics and practices that publish their own rates. It also covers the part most price roundups skip, which is that the regulatory status of what you are buying varies enormously by product, and that difference explains a large share of the price gap. This is a cost guide, not medical advice, and nothing here is a statement about whether any of these treatments work.
What Does Stem Cell Therapy Cost Without Insurance?
| Service/Type | Low | Average | High |
|---|---|---|---|
| PRP injection, one joint (the cheaper alternative) | $350 | $1,250 | $1,500 |
| Stem cell injection, one knee joint | $3,500 | $5,750 | $8,000 |
| Stem cell injection, knee joint plus bone | $6,000 | $9,000 | $12,000 |
| Stem cell therapy starting price, one joint | $3,500 | Not published | Not published |
| U.S. orthopedic stem cell therapy, per joint (market band) | $7,000 | Not published | $20,000 |
| U.S. full course of treatment | $5,000 | $20,000 | $50,000 |
| Exosome session, U.S. | $3,500 | $4,900 | $6,500 |
| Stem cell plus exosome joint injection, Mexico (published) | $2,325 | $3,475 | $4,625 |
| Combination IV stem cell plus exosome, Mexico (published) | $1,425 | Not published | Not published |
The middle column is a midpoint of published figures, not a national average. Nobody publishes a national average for a service that never touches a claims system.
Sources disagree on the full-course band and it is worth saying so plainly. Longevity Medical Institute’s 2026 global cost guide puts most single-course U.S. stem cell therapy between $5,000 and $50,000, with the most common band at $10,000 to $30,000, and cites a patient survey in which 30% spent $5,000 or less, 40% spent $10,000 to $25,000 and 10% spent more than $25,000. Individual orthopedic practices publish much narrower ranges because they are quoting one procedure rather than a program.
Stem cell knee injection cost
The knee is where most people meet this market, and it is where published pricing is best. Texas Orthobiologics in Dallas, an orthopedic surgery practice, states in a post updated August 2026 that an injection into the knee joint space alone runs $3,500 to $8,000, and that adding an intra-osseous injection placing cells into the bone beneath the worn cartilage runs $6,000 to $12,000. Stem Cell Carolina in Charlotte lists stem cell therapy starting from $3,500 per joint as of March 2026, and prices PRP separately starting from $1,250.
Both practices make the same point about the price spread: which preparation is used, how many structures are treated in one visit and whether the material is measured all move the number, and a cheaper quote is not automatically a worse preparation. Ask what the source material is, how it is concentrated and whether anyone measures what was actually delivered.
Compare that against the alternatives before you commit. A cortisone shot runs a small fraction of these prices, gel injections sit in the middle, and a PRP injection is roughly a quarter of a stem cell injection. At the other end, a knee replacement is a different order of magnitude in both cost and commitment.
Exosome therapy cost
Exosomes are sold as a lower-priced sibling to stem cells, and the published prices land in a fairly tight band. BioInformant, a stem cell market research firm, reported in a page updated November 6, 2025 that U.S. exosome treatments average $3,500 to $6,500 with the most common price point around $4,900, delivered either by IV infusion for systemic use or by local injection for orthopedic use.
Cross-border pricing runs lower. Longevity Medical Institute publishes combination stem cell plus exosome joint injections from $2,325 to $4,625 per region and combination IV stem cell plus exosome therapy from $1,425, with 16% Mexican IVA added on top.
One fact matters more than any of these numbers: FDA states there are currently no FDA-approved exosome products, and that exosome products intended to treat disease generally require FDA approval. That is not a nuance, it is the whole regulatory picture for this line item.
What Drives the Price
What is actually in the vial. This is the biggest driver and the one most often obscured. There is no FDA-approved amniotic fluid or umbilical cord blood product sold in the United States that contains living stem cells, a point Texas Orthobiologics makes on its own pricing page. A clinic selling one of those as a living stem cell injection is not delivering what the patient believes they are buying, whatever it costs. Autologous procedures using your own bone marrow or fat are a smaller and more comparable group.
Cell dose and how many areas are treated. Price scales with the amount of material prepared and the number of structures injected in one session. Treating one knee joint is a different purchase from treating a joint plus the bone beneath it, which is the $3,500 to $8,000 versus $6,000 to $12,000 split at Texas Orthobiologics.
Whether it is a procedure or a program. A single injection has a price. A multi-week systemic protocol with diagnostics, imaging review, labs, follow-up and adjunct therapies is a bundle, and that is what pushes quotes into the $10,000 to $30,000 band. Ask whether the quote covers one joint, one session or a full program.
Imaging guidance and who holds the needle. Ultrasound-guided injection performed by the physician who evaluated you costs more than a landmark-guided injection delivered by staff. Stem Cell Carolina prices real-time ultrasound guidance into every procedure rather than as an add-on, and explains its higher per-session PRP price that way.
Geography and regulatory regime. Longevity Medical Institute’s own comparison puts U.S. orthopedic applications at $7,000 to $20,000 per joint against $3,500 to $8,000 per joint in Mexico, and U.S. systemic protocols at $20,000 to $50,000 or more against $8,000 to $20,000. Cheaper is not automatically better value, and cross-border treatment means giving up U.S. legal recourse.
Cash Price vs. Insurance
There is essentially no insurance side to this market, and the reason is regulatory rather than actuarial.
FDA’s list of approved cellular and gene therapy products, current as of August 18, 2026, contains 53 licensed products. The stem cell products on it are overwhelmingly cord-blood-derived hematopoietic products approved for disorders of the blood-forming system, plus a small number of specialty cell therapies. FDA’s consumer pages state that regenerative medicine therapies have not been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain, nor for any neurological, cardiovascular or pulmonary disease, nor for autism, macular degeneration, blindness, chronic pain or fatigue.
FDA goes further than that on its patient information page, telling consumers that if they are being charged for these products outside a clinical trial with FDA oversight, the product is likely being offered illegally. The same page notes that a listing on clinicaltrials.gov, or a firm being registered with FDA, does not mean a product is legally marketed. That is a distinction clinics use in their marketing and consumers routinely misread.
Enforcement is live and current. On August 14, 2026, FDA issued a warning letter to R3 Medical Companies of Scottsdale, Arizona covering umbilical cord and exosome products marketed under the ReBella names, stating that the products are unapproved new drugs and unlicensed biological products and citing manufacturing violations found during inspections in November and December 2025.
For a self-pay patient, the practical consequences are simple. Insurance will not pay, so there is no allowed amount and no network discount. There is also no surprise balance bill, because the posted price is the whole price. And because there is no insurer setting a rate, comparison shopping actually works here in a way it does not elsewhere in healthcare. Our fair price checker is a fast way to sanity-check a quote against the figures on this page.
HSA and FSA cards sometimes work depending on the plan administrator, which is worth confirming before you pay rather than after.
How to Pay Less
-
Price the cheaper rungs of the ladder first. For joint pain, physical therapy, a cortisone shot and a PRP injection all cost a fraction of a stem cell injection and all have real published prices. Many clinics that sell stem cell therapy will tell you PRP is sufficient for your case if you ask directly.
-
Get the quote itemized in writing before you agree. Ask what the product is, whether it contains living cells, how many joints or regions the price covers, whether imaging and labs are bundled, and what follow-up is included. Clinics that publish prices will put this in writing. Clinics that will not name a number until you are in the chair are telling you something.
-
Convert program quotes to a per-procedure number. A $20,000 program and a $6,000 injection are not comparable until you know how many sessions and how many regions each covers. Do that division before you compare two clinics.
-
Ask about a cash or prepay discount and a payment plan separately. These are elective, prepaid purchases and clinics have room to move on both. Ask specifically whether financing changes the price, because at many clinics a medical credit card disqualifies you from discount pricing. Ask too about bilateral pricing: Stem Cell Carolina prices both knees in one session more favorably than two separate procedures, because the draw and processing happen once.
-
Do not let a wellness invoice become a collections problem. Cash-pay regenerative medicine invoices are consumer debt like any other. If one has already gone unpaid, our guides on negotiating medical bills and medical bills in collections apply, and the negotiation script works the same way it does on a hospital balance.
-
If cost is the barrier to basic care, start with the safety net. A free or sliding-scale clinic can handle evaluation and conservative management at a fraction of a regenerative medicine consult, and will refer you if something more is needed.
The Bottom Line
Budget $3,500 to $8,000 for a stem cell injection into one knee joint, $6,000 to $12,000 if the bone is treated too, and $10,000 to $30,000 for a full program in the United States as of September 2026. Exosome sessions cluster near $4,900. Nothing on that list is covered by insurance.
Before you pay, get in writing what the product is and where it sits with FDA, because that single answer explains most of the price differences you will see between clinics. Then price the cheaper alternatives for the same problem, because they are often the ones with published outcomes and published prices.
If you are researching cash-pay recovery services more broadly, our guides to hyperbaric oxygen therapy cost, peptide therapy cost and IV therapy cost cover the same kind of market, where the posted price is the real price and the regulatory footing is the thing to check first.